本文已被:浏览 272次 下载 216次
Received:November 18, 2025 Published Online:September 24, 2026
Received:November 18, 2025 Published Online:September 24, 2026
中文摘要: 糖尿病肾病是糖尿病患者常见的微血管病变,同时也是导致终末期肾病的首要原因。现有研究表明,脂代谢异常在糖尿病肾病的发病机制中扮演着重要角色,其通过影响肾脏多种细胞(包括肾小管上皮细胞、足细胞、系膜细胞、巨噬细胞)的功能状态,进而参与疾病的发生、进展或保护过程。调控脂代谢紊乱已成为糖尿病肾病研究的热点之一,本文系统阐述了脂代谢紊乱在糖尿病肾病发生发展中的作用,以期为防治糖尿病肾病领域的研究人员提供一定的研究思路和方向。
Abstract:Diabetic kidney disease(DKD)is a common and severe microvascular complication of diabetes mellitus and serves as a primary cause of end-stage renal disease. Accumulating evidence indicates that dyslipidemia plays a crucial role in the pathogenesis of DKD. It affects the functional status of various renal cells,including renal tubular epithelial cells,podocytes,mesangial cells,and macrophages,thereby participating in the occurrence,progression,or protection of the disease. Consequently,the regulation of lipid metabolism disorders has become a research hotspot in DKD. This article systematically elaborates on the role of dyslipidemia in the development of DKD,aiming to provide novel research insights and directions for researchers in the field of DKD prevention and treatment.
文章编号: 中图分类号:R587.2 文献标志码:A
基金项目:山西省基础研究计划(自然科学研究面上项目)(202403021221276)
引用文本:
